Multiple Bone Metastases From Non‐Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report

Combination therapy with EV and pembrolizumab was also effective in treating NMIBC with multiple bone metastases.

Authors

Institutions

Publication Details

Journal
IJU Case Reports
Published
2025-12-25
DOI
https://doi.org/10.1002/iju5.70119
Primary Topic
Bladder and Urothelial Cancer Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Multiple Bone Metastases From Non‐Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report

Ryoji Arata, Kaori Hino, Mototsune Kakizaki, Yasuhiro Nishiyama et al.
IJU Case Reports
Bladder and Urothelial Cancer Treatments
article

Multiple Bone Metastases From Non‐Muscle Invasive Bladder Cancer Responding to Combination Therapy With Enfortumab Vedotin and Pembrolizumab: A Case Report

Ryoji Arata, Kaori Hino, Mototsune Kakizaki, Yasuhiro Nishiyama, Kazuma Tsuboi, Shinkuro Yamamoto, S Kanemoto, Keiji Inoue, Noriaki Ono, Satoshi Fukata
article en

Abstract

Combination therapy with EV and pembrolizumab was also effective in treating NMIBC with multiple bone metastases.

IJU Case ReportsVol. 9(1)
CHI Health (US), Kochi Medical School Hospital (JP)
Good health and well-being
Openalex Percentile: Top 26%
Bladder and Urothelial Cancer Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.